Efficacy and Safety of Low-Dose Lenvatinib and Toripalimab in Patients With Recurrent Platinum-Resistant Ovarian Cancer: Study Protocol of a Multicenter, Open-Label, Single-Arm, Phase II Clinical Trial

Su H, Shang X, Liu H, Wang Y, Yu Y, Xu Y, Jiang K, Feng F

International Journal of Women's Health 2025, 17:325-333

Published Date: 6 February 2025